Viewing Study NCT02218294

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-03-02 @ 8:05 AM
Study NCT ID: NCT02218294
Status: COMPLETED
Last Update Posted: 2014-10-29
First Post: 2014-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Determine How BCX4161 is Metabolized and Eliminated by the Body
Sponsor: BioCryst Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Angioedema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BCX4161 View
None BioCryst View
None hereditary angioedema View
None mass balance View
None kallikrein inhibitor View
None ADME View